Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Control Release ; 168(3): 307-16, 2013 Jun 28.
Article in English | MEDLINE | ID: mdl-23578846

ABSTRACT

A lot of research has been carried out in the last decade to find a cure for neurodegenerative diseases especially Parkinson's disease but to little avail. In this study we have demonstrated the use of poly(lactic-co-glycolic acid) (PLGA)/collagen biodegradable microparticles formed using water-in-oil-in-water (W/O/W) double emulsion method, as a neurotrophic factor delivery vehicle. The microparticles were encapsulated with glial cell-derived neurotrophic factor (GDNF) fused with collagen binding peptide (CBP) immobilized to the inner collagen phase. The novelty lies in the strict regulation of release of GDNF-CBP from the microparticles as compared to a burst release from standard microparticles. The microparticles were demonstrated to be non-cytotoxic till 300 µg/2 × 105 cells and revealed a maximum release of 250 ng GDNF-CBP/mg microparticles in 0.3% collagenase. Differentiation of neural progenitor cells (NPCs) into mature neurons was demonstrated by co-culturing microparticles with cells in a medium containing collagenase which enabled the release of encapsulated GDNF-CBP, signaling the differentiation of NPCs into microtubule-associated protein 2 (MAP2)-expressing neurons. The successful ability of these microparticles to deliver neurotrophic factors and allow differentiation of NPCs into mature neurons provides some scope in its use for the treatment of Parkinson's disease and other neurodegenerative diseases.


Subject(s)
Collagen/chemistry , Glial Cell Line-Derived Neurotrophic Factor/chemistry , Lactic Acid/chemistry , Peptide Fragments/chemistry , Polyglycolic Acid/chemistry , Sialoglycoproteins/chemistry , Cell Differentiation , Cell Survival/drug effects , Cells, Cultured , Glial Cell Line-Derived Neurotrophic Factor/administration & dosage , Humans , Neural Stem Cells/cytology , Neural Stem Cells/drug effects , Neurons/cytology , Peptide Fragments/administration & dosage , Polylactic Acid-Polyglycolic Acid Copolymer , Recombinant Proteins/administration & dosage , Recombinant Proteins/chemistry , Sialoglycoproteins/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...